BIM
IDXX icon

Bridges Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bridges Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-451
Closed -$253K – 405
2026
Q1 		$253K Sell
451
-90
-17% -$57.7K ﹤0.01% 361
2025
Q4 		$366K Buy
541
+145
+37% +$98.7K ﹤0.01% 327
2025
Q3 		$253K Buy
+396
New +$240K ﹤0.01% 374
2024
Q3 		– Sell
-524
Closed -$255K – 405
2024
Q2 		$255K Buy
+524
New +$263K ﹤0.01% 361
2019
Q4 		– Sell
-1,999
Closed -$544K – 328
2019
Q3 		$544K Hold
1,999
– – 0.02% 278
2019
Q2 		$550K Buy
+1,999
New +$493K 0.02% 274

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Bridges Investment Management's IDXX Position: Q2 2026 in Review

Bridges Investment Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 451 shares — an estimated $253K sold.

Bridges Investment Management first reported a position in IDXX in Q2 2019 and held it in 6 quarters. The position peaked at $550K in Q2 2019. 764 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bridges Investment Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Bridges Investment Management sold 451 Idexx Laboratories shares in Q2 2026, an estimated $253K.
  • Bridges Investment Management first reported a position in Idexx Laboratories in Q2 2019 and held it in 6 quarters.
  • Bridges Investment Management's Idexx Laboratories position peaked at $550K in Q2 2019.
  • 764 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.